Aurobindo Pharma's arm recalls 2 antibiotic injections from US Medical Dialogues Bureau14 May 2018 2:12 PM ISTAuro Medics Pharma LLC, a US subsidiary of Aurobindo Pharma Ltd,has initiated voluntary recall of two lots each of two injections from the US market...
China's plans to import Indian drugs fail to enthuse Indian pharmaceutical firms Medical Dialogues Bureau14 May 2018 2:11 PM ISTChina's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the...
Fortis Healthcare shares fall nearly 3 percent Medical Dialogues Bureau14 May 2018 2:07 PM ISTNew Delhi: Shares of Fortis Healthcare fell nearly 3 percent today after the company announced that its board has picked the offer from...
Novartis India appoints Milan Paleja as vice chairman and MD Medical Dialogues Bureau13 May 2018 9:52 AM IST New Delhi: Drug firm Novartis India today announced the appointment of Milan Paleja as vice chairman and managing director, with effect from June...
Lupin, its JV submit new drug application for Etanercept biosimilar in Japan Medical Dialogues Bureau13 May 2018 9:12 AM ISTNew Delhi: Drug firm Lupin today said its Japanese arm and YL Biologics have submitted a new drug application (NDA) with the Japanese health regulator...
Indian IP and liabilities law barrier to pharma RnD investment Medical Dialogues Bureau13 May 2018 9:06 AM ISTBOSTON: India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, especially from the US, that...
ASSOCHAM urges greater utilisation of technology in pharmaceuticals Medical Dialogues Bureau13 May 2018 9:00 AM ISTNew Delhi: Advanced, affordable and accessible solutions are the only way forward towards intensifying the innovations in the Indian pharmaceutical...
Zydus Cadila gets USFDA nod for Carbidopa tablets Medical Dialogues Bureau12 May 2018 12:06 PM ISTZydus Cadila has received final approval from the US health regulator to market Carbidopa tablets, used for treating symptoms of Parkinson's disease....
FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients Medical Dialogues Bureau12 May 2018 12:00 PM ISTThe U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age...
Chinese medical devices maker forays into Indian market Medical Dialogues Bureau12 May 2018 9:06 AM ISTHyderabad: China-based Lepu Medical Technology (Beijing) Co. Ltd today said itis all set to make its foray into Indian medical devices and equipment...
Aurobindo Pharma LLC recalls over 1.5 million injections from Medical Dialogues Bureau12 May 2018 9:05 AM ISTHyderabad: Auromedics Pharma LLC,a US subsidiary of Aurobindo Pharma, has initiated voluntary recall of over 1.5 million bags of different anti biotic...
Cipla partners MannKind for marketing, distribution of Afrezza in India Medical Dialogues Bureau11 May 2018 10:58 AM ISTNew Delhi: Drug firm Cipla today said it has entered into an exclusive marketing and distribution agreement with US-based MannKind Corporation for...
